# LitéoMed - Transform Your Oncology Practice: From Complexity to Precision
# https://www.liteomed.com

## Company Information
- **Name**: LitéoMed
- **Industry**: Healthcare Technology / Medical AI
- **Founded**: 2023
- **Location**: France
- **Contact**: contact@liteomed.com

## Product Overview
LitéoMed accelerates precision oncology with collaborative AI. Free up time for your patients, optimize clinical decisions, and access the insights that truly matter. Save 30% of time per patient and identify critical biomarkers 3x faster.

## Key Features
- **Save 30% of Time per Patient**: Automate complex data analysis and focus on patient care
- **AI-Augmented Diagnostics**: Identify critical biomarkers 3x faster with reduced clinical uncertainty
- **You Keep Control**: AI proposes, you decide - your clinical expertise remains sovereign
- **Every Recommendation Justified**: Access scientific evidence, consult sources, understand AI reasoning
- **Optimized Workflow**: Intuitive interface with instant switch between diagnostics and therapy
- **Always Up-to-Date**: Latest guidelines integrated with automatic updates
- **Instant Validation**: Real-time verification with immediate access to evidence
- **Continuous Learning**: AI learns from your decisions and adapts to your practice

## Target Audience
- Oncology departments seeking to optimize workflow
- Healthcare professionals focused on precision medicine
- Clinical teams aiming to reduce diagnostic time by 40%
- Medical institutions targeting positive ROI within 6 months
- 200+ European oncologists already in pilot program

## Languages Supported
- English (EN)
- French (FR)

## Compliance & Security
- **End-to-End Encryption**: Maximum security for patient data
- **HDS Certified Hosting**: Your data stays in Europe
- **GDPR Compliance Guaranteed**: Full regulatory compliance
- **24h Deployment**: Without service interruption
- **Native Integration**: With major PACS and HIS systems

## Development Status
- **Validated by European Oncology Experts**: Including Prof. Philip Poortmans (Former President European Cancer Organization)
- **200+ European Oncologists Ready**: Active pilot program
- **Proven Results**: reduction in diagnostic time, improvement in therapeutic precision
- **Demo Available**: Personalized demonstration in 20 minutes

## Medical Disclaimer
This platform is designed to assist healthcare professionals and does not replace clinical judgment. All medical decisions should be made by qualified healthcare professionals. The content provided is for informational purposes only and should not be considered as medical advice. AI proposes, clinicians decide - your expertise remains sovereign.

## Key URLs
- Homepage: https://www.liteomed.com
- Preview Access: https://www.liteomed.com/user_waiting_lists/new
- Privacy Policy: https://www.liteomed.com/privacy
- Investor Information: https://www.liteomed.com/investors/new

## Keywords
AI, artificial intelligence, oncology, precision medicine, healthcare, cancer treatment, clinical decision support, medical AI, oncology platform, healthcare professionals, patient care, treatment planning, augmented diagnostics, biomarkers, optimized workflow, positive ROI 6 months, diagnostic time reduction, collaborative AI, HDS certified, GDPR compliant, European oncologists, instant validation, continuous learning

---
Last updated: July 2025
Copyright © 2023-2025 LitéoMed SAS. All rights reserved.